CEPLENE

This brand name is authorized in Austria, Croatia, Estonia, Ireland, Lithuania, Poland, Romania.

Active ingredients

The drug CEPLENE contains one active pharmaceutical ingredient (API):

1	Histamine UNII 3POA0Q644U - HISTAMINE DIHYDROCHLORIDE
	Histamine/IL-2 is an immunotherapy which aims to induce immune-mediated destruction of residual myeloid leukaemic cells and thereby to prevent relapse of leukaemia. The role of histamine is to protect lymphocytes, in particular NK cells and T cells, which are responsible for the immune-mediated destruction of residual leukaemic cells.
	Read more about Histamine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
CEPLENE Solution for injection	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
L03AX14	Histamine dihydrochloride	L Antineoplastic and immunomodulating agents → L03 Immunostimulants → L03A Immunostimulants → L03AX Other immunostimulants
Discover more medicines within L03AX14

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1382262
LT	Valstybinė vaistų kontrolės tarnyba	1034469
PL	Rejestru Produktów Leczniczych	100127424
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W53539001